Madrigal Pharmaceuticals Inc (MDGL)
302.67
-12.48
(-3.96%)
USD |
NASDAQ |
Nov 14, 16:00
303.04
+0.37
(+0.12%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash from Operations (Quarterly): -66.98M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -66.98M |
| June 30, 2024 | -134.94M |
| March 31, 2024 | -149.16M |
| December 31, 2023 | -79.93M |
| September 30, 2023 | -84.92M |
| June 30, 2023 | -75.31M |
| March 31, 2023 | -84.07M |
| December 31, 2022 | -58.52M |
| September 30, 2022 | -59.07M |
| June 30, 2022 | -57.36M |
| March 31, 2022 | -49.91M |
| December 31, 2021 | -48.05M |
| September 30, 2021 | -45.56M |
| June 30, 2021 | -46.88M |
| March 31, 2021 | -43.43M |
| December 31, 2020 | -54.95M |
| September 30, 2020 | -47.85M |
| June 30, 2020 | -24.26M |
| March 31, 2020 | -30.51M |
| December 31, 2019 | -12.28M |
| September 30, 2019 | -11.32M |
| June 30, 2019 | -11.54M |
| March 31, 2019 | -6.478M |
| December 31, 2018 | -6.265M |
| September 30, 2018 | -5.238M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.36M |
| March 31, 2018 | -8.644M |
| December 31, 2017 | -5.945M |
| September 30, 2017 | -4.951M |
| June 30, 2017 | -7.65M |
| March 31, 2017 | -3.771M |
| December 31, 2016 | -5.28M |
| September 30, 2016 | -9.243M |
| June 30, 2016 | -2.647M |
| March 31, 2016 | -0.438M |
| December 31, 2015 | -1.096M |
| September 30, 2015 | 34.46M |
| June 30, 2015 | -17.73M |
| March 31, 2015 | -18.78M |
| December 31, 2014 | -19.22M |
| September 30, 2014 | -18.57M |
| June 30, 2014 | -20.87M |
| March 31, 2014 | -20.27M |
| December 31, 2013 | -18.69M |
| September 30, 2013 | -16.59M |
| June 30, 2013 | -19.92M |
| March 31, 2013 | -22.21M |
| December 31, 2012 | -12.52M |
| September 30, 2012 | -13.26M |
| June 30, 2012 | -13.10M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-149.16M
Minimum
Mar 2024
-12.28M
Maximum
Dec 2019
-62.70M
Average
-56.15M
Median
Cash from Operations (Quarterly) Benchmarks
| ADMA Biologics Inc | 25.03M |
| 89bio Inc | -145.36M |
| Corcept Therapeutics Inc | 73.83M |
| Sarepta Therapeutics Inc | -70.70M |
| Matinas BioPharma Holdings Inc | -3.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -202.39M |
| Cash from Financing (Quarterly) | 7.462M |
| Free Cash Flow | -438.32M |
| Free Cash Flow Per Share (Quarterly) | -3.116 |
| Free Cash Flow to Equity (Quarterly) | -68.24M |
| Free Cash Flow Yield | -6.99% |